Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 5 (May)

1. An unusual case of weight loss in a patient with refractory rheumatoid arthritis.
   Age Ageing, 34(3): 305-6. [Abstract] [Full-text]
2. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
   Eur J Immunol, 35(5): 1643-52. [Abstract] [Full-text]
3. Blocking IL-1 in systemic inflammation.
   J Exp Med, 201(9): 1355-9. [Abstract] [Full-text]
4. Infliximab therapy in established rheumatoid arthritis: an observational study.
   Am J Med, 118(5): 515-20. [Abstract] [Full-text]
5. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.
   J Exp Med, 201(9): 1479-86. [Abstract] [Full-text]
6. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
   J Pediatr, 146(5): 598-604. [Abstract] [Full-text]
7. Angiopoietin-like-4 is a potential angiogenic mediator in arthritis.
   Clin Immunol, 115(1): 93-101. [Abstract] [Full-text]
8. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
   Eye, 19(5): 535-9. [Abstract] [Full-text]
9. Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature.
   J Clin Microbiol, 43(5): 2537-41. [Abstract] [Full-text]
10. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.
    Adv Drug Deliv Rev, 57(7): 973-93. [Abstract] [Full-text]
11. A linguistic framework for assessing the quality of written patient information: its use in assessing methotrexate information for rheumatoid arthritis.
    Health Educ Res, 20(3): 334-44. [Abstract] [Full-text]
12. Fluorescent characteristics of rheumatoid arthritis patients blood lymphocytes.
    J Fluoresc, 15(2): 105-10. [Abstract] [Full-text]
13. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats.
    Inflamm Res, 54(3): 127-32. [Abstract] [Full-text]
14. Induction of oral tolerance in experimental Sjogren's syndrome autoimmunity.
    Scand J Immunol, 61(5): 418-25. [Abstract] [Full-text]
15. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction.
    Clin Immunol, 115(2): 118-28. [Abstract] [Full-text]
16. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
    Arthritis Rheum, 52(5): 1392-401. [Abstract] [Full-text]
17. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Arthritis Rheum, 52(5): 1360-70. [Abstract] [Full-text]
18. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.
    Arthritis Rheum, 52(5): 1534-44. [Abstract] [Full-text]
19. Association between single-nucleotide polymorphisms in the SEC8L1 gene, which encodes a subunit of the exocyst complex, and rheumatoid arthritis in a Japanese population.
    Arthritis Rheum, 52(5): 1371-80. [Abstract] [Full-text]
20. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis.
    Arthritis Rheum, 52(5): 1402-10. [Abstract] [Full-text]
21. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.
    Arthritis Rheum, 52(5): 1381-91. [Abstract] [Full-text]
22. Congenital heart block associated with undiagnosed maternal Primary Sjögren's Syndrome -- a case report and discussion.
    Oral Dis, 11(3): 190-2. [Abstract] [Full-text]
23. Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis.
    Rheumatol Int, 25(4): 285-91. [Abstract] [Full-text]
24. Cricoarytenoid arthritis in Sjögren's syndrome.
    Rheumatol Int, 25(4): 301-2. [Abstract] [Full-text]
25. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
    Rheumatol Int, 25(4): 311-3. [Abstract] [Full-text]
26. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.
    Rheumatol Int, 25(4): 241-5. [Abstract] [Full-text]
27. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.
    Rheumatol Int, 25(4): 280-4. [Abstract] [Full-text]
28. Manometric assessment of esophageal motility in patients with primary Sjögren's syndrome.
    Rheumatol Int, 25(4): 246-9. [Abstract] [Full-text]
29. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis.
    Autoimmun Rev, 4(4): 201-6. [Abstract] [Full-text]
30. Favourable social functioning and health related quality of life of patients with JIA in early adulthood.
    Ann Rheum Dis, 64(6): 875-80. [Abstract] [Full-text]
31. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients.
    Ann Rheum Dis, 64(6): 871-4. [Abstract] [Full-text]
32. Impaired early B cell tolerance in patients with rheumatoid arthritis.
    J Exp Med, 201(10): 1659-67. [Abstract] [Full-text]
33. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
    Clin Nutr, 24(3): 442-54. [Abstract] [Full-text]
34. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis.
    Tissue Antigens, 65(6): 544-8. [Abstract] [Full-text]
35. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(6): 834-8. [Abstract] [Full-text]
36. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
    Ann Rheum Dis, 64(6): 958-60. [Abstract] [Full-text]
37. Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept.
    Ann Rheum Dis, 64(6): 899-905. [Abstract] [Full-text]
38. Infliximab treatment in ankylosing spondylitis: an observational study.
    Ann Rheum Dis, 64(6): 940-2. [Abstract] [Full-text]
39. Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.
    Ann Rheum Dis, 64(6): 865-70. [Abstract] [Full-text]
40. What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).
    Rheumatology (Oxford), 44(6): 796-9. [Abstract] [Full-text]
41. The cost of glucocorticoid-associated adverse events in rheumatoid arthritis.
    Rheumatology (Oxford), 44(6): 781-8. [Abstract] [Full-text]
42. Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis.
    Rheumatology (Oxford), 44(6): 806-12. [Abstract] [Full-text]
43. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
    Rheumatology (Oxford), 44(6): 729-34. [Abstract] [Full-text]
44. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.
    Rheumatology (Oxford), 44(6): 789-95. [Abstract] [Full-text]
45. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis.
    Rheumatology (Oxford), 44(6): 762-7. [Abstract] [Full-text]
46. Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring system.
    Rheumatology (Oxford), 44(6): 768-72. [Abstract] [Full-text]
47. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.
    Rheumatology (Oxford), 44(6): 777-80. [Abstract] [Full-text]
48. Wnt signalling in rheumatoid arthritis.
    Rheumatology (Oxford), 44(6): 708-13. [Abstract] [Full-text]
49. Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy.
    Rheumatology (Oxford), 44(6): 721-8. [Abstract] [Full-text]
50. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Clin Geriatr Med, 21(3): 649-69, viii. [Abstract] [Full-text]
51. Rheumatic disease in the elderly: rheumatoid arthritis.
    Clin Geriatr Med, 21(3): 513-25, vi. [Abstract] [Full-text]
52. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.
    Pharmacol Rev, 57(2): 163-72. [Abstract] [Full-text]
53. Establishment of a simple and quantitative immunospot assay for detecting anti-type II collagen antibody using an infrared fluorescence imaging system (IFIS).
    J Immunol Methods, 299(1): 189-98. [Abstract] [Full-text]
54. Sparing of age-related macular degeneration in rheumatoid arthritis.
    Neurobiol Aging, 26(8): 1199-203. [Abstract] [Full-text]
55. Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography.
    J Clin Endocrinol Metab, 90(6): 3168-73. [Abstract] [Full-text]
56. Spondyloarthritis: update on pathogenesis and management.
    Am J Med, 118(6): 592-603. [Abstract] [Full-text]
57. Hydroxyapatite-coated total knee arthroplasty in rheumatoid arthritis patients: a short-term follow-up study.
    J Coll Physicians Surg Pak, 15(6): 333-7. [Abstract] [Full-text]
58. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
    Pharmacology, 74(2): 100-5. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.